BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19294466)

  • 1. Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines).
    Goudet P; Murat A; Cardot-Bauters C; Emy P; Baudin E; du Boullay Choplin H; Chapuis Y; Kraimps JL; Sadoul JL; Tabarin A; Vergès B; Carnaille B; Niccoli-Sire P; Costa A; Calender A;
    World J Surg; 2009 Jun; 33(6):1197-207. PubMed ID: 19294466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymic neuroendocrine tumour in multiple endocrine neoplasia type 1: female patients are not rare exceptions.
    Sakurai A; Imai T; Kikumori T; Horiuchi K; Okamoto T; Uchino S; Kosugi S; Suzuki S; Suyama K; Yamazaki M; Sato A;
    Clin Endocrinol (Oxf); 2013 Feb; 78(2):248-54. PubMed ID: 22690831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d'etude des Tumeurs Endocrines.
    Goudet P; Bonithon-Kopp C; Murat A; Ruszniewski P; Niccoli P; Ménégaux F; Chabrier G; Borson-Chazot F; Tabarin A; Bouchard P; Cadiot G; Beckers A; Guilhem I; Chabre O; Caron P; Du Boullay H; Verges B; Cardot-Bauters C
    Eur J Endocrinol; 2011 Jul; 165(1):97-105. PubMed ID: 21551167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unraveling the intrafamilial correlations and heritability of tumor types in MEN1: a Groupe d'étude des Tumeurs Endocrines study.
    Thevenon J; Bourredjem A; Faivre L; Cardot-Bauters C; Calender A; Le Bras M; Giraud S; Niccoli P; Odou MF; Borson-Chazot F; Barlier A; Lombard-Bohas C; Clauser E; Tabarin A; Pasmant E; Chabre O; Castermans E; Ruszniewski P; Bertherat J; Delemer B; Christin-Maitre S; Beckers A; Guilhem I; Rohmer V; Goichot B; Caron P; Baudin E; Chanson P; Groussin L; Du Boullay H; Weryha G; Lecomte P; Schillo F; Bihan H; Archambeaud F; Kerlan V; Bourcigaux N; Kuhn JM; Vergès B; Rodier M; Renard M; Sadoul JL; Binquet C; Goudet P
    Eur J Endocrinol; 2015 Dec; 173(6):819-26. PubMed ID: 26392472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d'étude des Tumeurs Endocrines.
    Goudet P; Dalac A; Le Bras M; Cardot-Bauters C; Niccoli P; Lévy-Bohbot N; du Boullay H; Bertagna X; Ruszniewski P; Borson-Chazot F; Vergès B; Sadoul JL; Ménégaux F; Tabarin A; Kühn JM; d'Anella P; Chabre O; Christin-Maitre S; Cadiot G; Binquet C; Delemer B
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1568-77. PubMed ID: 25594862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymic carcinoids in multiple endocrine neoplasia type 1.
    Teh BT; Zedenius J; Kytölä S; Skogseid B; Trotter J; Choplin H; Twigg S; Farnebo F; Giraud S; Cameron D; Robinson B; Calender A; Larsson C; Salmela P
    Ann Surg; 1998 Jul; 228(1):99-105. PubMed ID: 9671073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and prognosis of thymic neuroendocrine tumours associated with multiple endocrine neoplasia type 1: A single-centre study, systematic review and meta-analysis.
    Ye L; Wang W; Ospina NS; Jiang L; Christakis I; Lu J; Zhou Y; Zhu W; Cao Y; Wang S; Perrier ND; Young WF; Ning G; Wang W
    Clin Endocrinol (Oxf); 2017 Dec; 87(6):706-716. PubMed ID: 28940393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-Year Postoperative Mortality in MEN1 Patients Operated on Gastric and Duodenopancreatic Neuroendocrine Tumors: An AFCE and GTE Cohort Study.
    Christou N; Mathonnet M; Gaujoux S; Cadiot G; Deguelte S; Kraimps JL; Lifante JC; Menegaux F; Mirallié E; Muscari F; Carnaille B; Pattou F; Sauvanet A; Goudet P
    World J Surg; 2019 Nov; 43(11):2856-2864. PubMed ID: 31384998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients.
    Goudet P; Murat A; Binquet C; Cardot-Bauters C; Costa A; Ruszniewski P; Niccoli P; Ménégaux F; Chabrier G; Borson-Chazot F; Tabarin A; Bouchard P; Delemer B; Beckers A; Bonithon-Kopp C
    World J Surg; 2010 Feb; 34(2):249-55. PubMed ID: 19949948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'etude des Tumeurs Endocrines database.
    Gatta-Cherifi B; Chabre O; Murat A; Niccoli P; Cardot-Bauters C; Rohmer V; Young J; Delemer B; Du Boullay H; Verger MF; Kuhn JM; Sadoul JL; Ruszniewski P; Beckers A; Monsaingeon M; Baudin E; Goudet P; Tabarin A
    Eur J Endocrinol; 2012 Feb; 166(2):269-79. PubMed ID: 22084155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic Potential and Survival of Duodenal and Pancreatic Tumors in Multiple Endocrine Neoplasia Type 1: A GTE and AFCE Cohort Study (Groupe d'étude des Tumeurs Endocrines and Association Francophone de Chirurgie Endocrinienne).
    Vinault S; Mariet AS; Le Bras M; Mirallié E; Cardot-Bauters C; Pattou F; Ruszniewski P; Sauvanet A; Chanson P; Baudin E; Elias D; Menegaux F; Gaujoux S; Borson-Chazot F; Lifante JC; Caron P; Carrère N; Tabarin A; Laurent C; Klein M; Brunaud L; Niccoli P; Sebag F; Cadiot G; Kianmanesh R; Luu M; Binquet C; Goudet P
    Ann Surg; 2020 Dec; 272(6):1094-1101. PubMed ID: 30585820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
    Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
    Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologically Proven Bronchial Neuroendocrine Tumors in MEN1: A GTE 51-Case Cohort Study.
    Lecomte P; Binquet C; Le Bras M; Tabarin A; Cardot-Bauters C; Borson-Chazot F; Lombard-Bohas C; Baudin E; Delemer B; Klein M; Vergès B; Aparicio T; Cosson E; Beckers A; Caron P; Chabre O; Chanson P; Du Boullay H; Guilhem I; Niccoli P; Rohmer V; Guigay J; Vulpoi C; Scoazec JY; Goudet P
    World J Surg; 2018 Jan; 42(1):143-152. PubMed ID: 28785839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Features, Treatments, and Outcomes of Patients with Thymic Carcinoids and Multiple Endocrine Neoplasia Type 1 Syndrome at MD Anderson Cancer Center.
    Christakis I; Qiu W; Silva Figueroa AM; Hyde S; Cote GJ; Busaidy NL; Williams M; Grubbs E; Lee JE; Perrier ND
    Horm Cancer; 2016 Aug; 7(4):279-87. PubMed ID: 27311764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort study.
    Thevenon J; Bourredjem A; Faivre L; Cardot-Bauters C; Calender A; Murat A; Giraud S; Niccoli P; Odou MF; Borson-Chazot F; Barlier A; Lombard-Bohas C; Clauser E; Tabarin A; Parfait B; Chabre O; Castermans E; Beckers A; Ruszniewski P; Le Bras M; Delemer B; Bouchard P; Guilhem I; Rohmer V; Goichot B; Caron P; Baudin E; Chanson P; Groussin L; Du Boullay H; Weryha G; Lecomte P; Penfornis A; Bihan H; Archambeaud F; Kerlan V; Duron F; Kuhn JM; Vergès B; Rodier M; Renard M; Sadoul JL; Binquet C; Goudet P
    Hum Mol Genet; 2013 May; 22(10):1940-8. PubMed ID: 23376981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1.
    Thomas-Marques L; Murat A; Delemer B; Penfornis A; Cardot-Bauters C; Baudin E; Niccoli-Sire P; Levoir D; Choplin Hdu B; Chabre O; Jovenin N; Cadiot G;
    Am J Gastroenterol; 2006 Feb; 101(2):266-73. PubMed ID: 16454829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatoduodenectomy for Neuroendocrine Tumors in Patients with Multiple Endocrine Neoplasia Type 1: An AFCE (Association Francophone de Chirurgie Endocrinienne) and GTE (Groupe d'étude des Tumeurs Endocrines) Study.
    Santucci N; Gaujoux S; Binquet C; Reichling C; Lifante JC; Carnaille B; Pattou F; Mirallié E; Facy O; Mathonnet M; Goudet P
    World J Surg; 2021 Jun; 45(6):1794-1802. PubMed ID: 33649917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India.
    Goroshi M; Bandgar T; Lila AR; Jadhav SS; Khare S; Shrikhande SV; Uchino S; Dalvi AN; Shah NS
    Fam Cancer; 2016 Oct; 15(4):617-24. PubMed ID: 26905068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic studies of thymic carcinoids in multiple endocrine neoplasia type 1.
    Teh BT; McArdle J; Chan SP; Menon J; Hartley L; Pullan P; Ho J; Khir A; Wilkinson S; Larsson C; Cameron D; Shepherd J
    Medicine (Baltimore); 1997 Jan; 76(1):21-9. PubMed ID: 9064485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymic carcinoid in multiple endocrine neoplasia 1: genotype-phenotype correlation and prevention.
    Lim LC; Tan MH; Eng C; Teh BT; Rajasoorya RC
    J Intern Med; 2006 Apr; 259(4):428-32. PubMed ID: 16594911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.